Hip, Knee Sales Growth Slows In Second Quarter For Top Orthopedic Firms
This article was originally published in The Gray Sheet
Executive Summary
Overall weakness in the hip-and-knee market resulted in low-single-digit reconstructive sales growth for Zimmer, Stryker and Johnson & Johnson/DePuy in the second quarter